Remission: Today’s Target in the Treatment of Mood and Anxiety Disorders
By Charles B. Nemeroff, MD, PhD
-
Intermittent Fluoxetine Dosing in the Treatment of Women With Premenstrual Dysphoria
By Meir Steiner, MD, PhD, FRCPC, Marilyn Korzekwa, MD, FRCPC, John Lamont, MD, MSc, FRCSC, and Annette Wilkins, BA
-
Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR
By Lindsay DeVane, PharmD
-
Efficacy and Tolerability of Controlled-Release Paroxetine
By Robert N. Golden, MD
-
A Discussion on the Methodologies Used to Evaluate Antidepressants
MODERATOR: Jan A. Fawcett, MD
DISCUSSANTS: Norman Sussman, MD Jeffrey H. Newcorn, MD
-
Risperidone: Review of Its Therapeutic Utility in Depression
By Joyce E. Myers, MD, and Michael E. Thase, MD
-
A Model to Explain the Therapeutic Effects of Serotonin Reuptake Inhibitors: The Role of 5-HT2 Receptors
By Mikael Landén, MD, PhD, and Michael E. Thase, MD
-
All GradWorks Special Projects are Subject to Medical Updates & are Available for Sponsorship via Unrestricted Educational Grant. -
Managing Deep Vein Thrombosis Risk in Oncology Patients Office and Outpatient Settings
MODERATOR: Brian A. Meltzer, MD, MBA
DISCUSSANTS: Leo R. Zacharski, MS, MD, and Steven R. Deitcher, MD
-
Novel Mechanisms in the Future of Cancer Treatment: Angiogenesis & Signal Transduction
MODERATOR: Michael Goldstein, MD
DISCUSSANTS: Roy S. Herbst, MD, PhD, and Michael S. Gordon, MD
-
All GradWorks Special Projects are Subject to Medical Updates & are Available for Sponsorship via Unrestricted Educational Grant. -
All GradWorks Special Projects are Subject to Medical Updates & are Available for Sponsorship via Unrestricted Educational Grant.
